Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | HK1 | P19367 | 1/20 | 0.39 |
| ▸ | HK2 | P52789 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28774531 | 0.81 | SLC5A2 (0.40) | LGALS3 | |
| SCHEMBL28928268 | 0.81 | EPHX1 (0.35) | EPHX1LGALS3 | |
| SCHEMBL27526484 | 0.81 | SLC5A2 (0.38) | — | |
| SCHEMBL13415299 | 0.80 | SLC5A2 (0.43) | EPHX1 | |
| SCHEMBL468525 | 0.80 | SLC5A2 (0.43) | EPHX1 | |
| SCHEMBL7681079 | 0.79 | SLC5A2 (0.49) | — | |
| SCHEMBL9809746 | 0.78 | SLC5A2 (0.37) | TDP1 | |
| SCHEMBL28650376 | 0.78 | SLC5A2 (0.49) | — | |
| SCHEMBL27554109 | 0.78 | SLC5A2 (0.38) | — | |
| P-Nitrophenol SCHEMBL27776317 | 0.76 | EPHX1 (0.41) | EPHX1LGALS3CYP1A2NFKB1THPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110305414-B | Polyolefin composition and process for preparing the same | 赣州蓝风科技有限公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-1303076-C | Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same | MILLIKEN & CO (US) | 2007-03-07 | — | — | CN | disclosed |
| CN-1293079-C | Process for preparing alditol acetals in high yields using mineral acids and surfactants | MILLIKEN & CO (US) | 2007-01-03 | — | — | CN | disclosed |
| CN-1511160-A | Process for preparing alditol acetals in high yields using mineral acids and surfactants | 美利肯公司 | 2004-07-07 | — | — | CN | disclosed |
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | MILLIKEN & COMPANY | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | SORD, ALDOA, DERA | EPHX1 3888/4885LGALS3 3368/4885CYP1A2 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.